Keyphrases
Heme oxygenase-1 (HO-1)
100%
Proteasome Inhibition
100%
Dopaminergic Neuroprotection
100%
Protease Inhibitors
21%
MG132
21%
Proteasome Activity
21%
Neuroprotection
14%
Patients with Parkinson's Disease
14%
Induced Toxicity
14%
6-hydroxydopamine (6-OHDA)
14%
Immunoreactivity
7%
Dopaminergic Neurons
7%
MRNA Expression
7%
Astrocytes
7%
Overexpressing
7%
PC12 Cells
7%
Protein Level
7%
PCR Analysis
7%
Mesencephalic
7%
Carbon Dioxide
7%
Co-treatment
7%
Quantitative RT-PCR
7%
Heme
7%
Bilirubin
7%
Lactacystin
7%
Postmortem Study
7%
Mesencephalic Culture
7%
Cytomegalovirus Promoter
7%
Catalytic Degradation
7%
Zinc Protoporphyrin IX
7%
Cycloheximide Chase
7%
Pharmacology, Toxicology and Pharmaceutical Science
Heme Oxygenase 1
100%
Neuroprotection
100%
Dopamine Receptor Stimulating Agent
100%
Proteasome
100%
Proteasome Inhibitor
21%
Parkinson's Disease
14%
Bilirubin
7%
Cytomegalovirus
7%
Benzyloxycarbonylleucylleucylleucinal
7%
Carbon Monoxide
7%
Heme
7%
Cycloheximide
7%
Oxidopamine
7%
Lactacystin
7%
Protoporphyrin IX
7%
Protoporphyrin Zinc
7%
Messenger RNA
7%
Neuroscience
Neuroprotection
100%
Heme Oxygenase 1
100%
Dopaminergic
100%
Proteasome
100%
Proteasome Inhibitor
21%
Parkinson's Disease
14%
Dopaminergic Neuron
7%
Astrocyte
7%
Promoter Region
7%
Cycloheximide
7%
Carbon Monoxide
7%
Bilirubin
7%
Oxidopamine
7%
Protoporphyrin Zinc
7%
Cytomegalovirus
7%
Heme
7%
Messenger RNA
7%
Biochemistry, Genetics and Molecular Biology
Heme Oxygenase
100%
Proteasome
100%
Dopaminergic
100%
Proteasome Inhibitor
21%
Promoter Region
7%
Immunoreactivity
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Astrocyte
7%
Cytomegalovirus
7%
MG132
7%
Cycloheximide
7%
Zinc Protoporphyrin
7%
Protoporphyrin IX
7%
Messenger RNA
7%
Bilirubin
7%
Immunology and Microbiology
Proteasome
100%
Heme
100%
Promoter Region
6%
Astrocyte
6%
Cytomegalovirus
6%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Immunoreactivity
6%
PC12 Cell Line
6%